Drug intelligence / Profile preview

notch1 siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

notch1 siRNA is a double-stranded RNA molecule designed to silence the expression of the Notch1 gene through the RNA interference (RNAi) pathway. Notch1 is a transmembrane receptor that plays a pivotal role in the Notch signaling pathway, which is frequently dysregulated in various cancers, including glioblastoma multiforme (GBM). In GBM, Notch1 signaling is associated with the maintenance of glioma-initiating cells (GICs), which contribute to tumor recurrence and resistance to standard therapies. By inducing the sequence-specific degradation of Notch1 mRNA, this siRNA reduces the stemness of GICs and enhances the efficacy of co-administered treatments. Research has explored its delivery via specialized vehicles, such as GIC-targeting exosomes, often in combination with other agents like mitoxantrone and interleukin-12, to reshape the immunosuppressive tumor microenvironment and prevent post-surgical recurrence.

Other names
siRNA targeting Notch1Notch1-siRNANotch-1-siRNANotch 1-siRNAsiRNA for Notch1small interfering RNA targeting Notch1
02

Targets

NOTCH (Neurogenic locus notch homolog protein 3)

Beyond the preview

Go deeper on notch1 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on notch1 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call